Final published version
Licence: CC BY: Creative Commons Attribution 4.0 International License
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition
AU - Frost, Julianty
AU - Galdeano, Carles
AU - Soares, Pedro
AU - Gadd, Morgan S
AU - Grzes, Katarzyna M
AU - Ellis, Lucy
AU - Epemolu, Ola
AU - Shimamura, Satoko
AU - Bantscheff, Marcus
AU - Grandi, Paola
AU - Read, Kevin D
AU - Cantrell, Doreen A
AU - Rocha, Sonia
AU - Ciulli, Alessio
PY - 2016/11/4
Y1 - 2016/11/4
N2 - Chemical strategies to using small molecules to stimulate hypoxia inducible factors (HIFs) activity and trigger a hypoxic response under normoxic conditions, such as iron chelators and inhibitors of prolyl hydroxylase domain (PHD) enzymes, have broad-spectrum activities and off-target effects. Here we disclose VH298, a potent VHL inhibitor that stabilizes HIF-α and elicits a hypoxic response via a different mechanism, that is the blockade of the VHL:HIF-α protein-protein interaction downstream of HIF-α hydroxylation by PHD enzymes. We show that VH298 engages with high affinity and specificity with VHL as its only major cellular target, leading to selective on-target accumulation of hydroxylated HIF-α in a concentration- and time-dependent fashion in different cell lines, with subsequent upregulation of HIF-target genes at both mRNA and protein levels. VH298 represents a high-quality chemical probe of the HIF signalling cascade and an attractive starting point to the development of potential new therapeutics targeting hypoxia signalling.
AB - Chemical strategies to using small molecules to stimulate hypoxia inducible factors (HIFs) activity and trigger a hypoxic response under normoxic conditions, such as iron chelators and inhibitors of prolyl hydroxylase domain (PHD) enzymes, have broad-spectrum activities and off-target effects. Here we disclose VH298, a potent VHL inhibitor that stabilizes HIF-α and elicits a hypoxic response via a different mechanism, that is the blockade of the VHL:HIF-α protein-protein interaction downstream of HIF-α hydroxylation by PHD enzymes. We show that VH298 engages with high affinity and specificity with VHL as its only major cellular target, leading to selective on-target accumulation of hydroxylated HIF-α in a concentration- and time-dependent fashion in different cell lines, with subsequent upregulation of HIF-target genes at both mRNA and protein levels. VH298 represents a high-quality chemical probe of the HIF signalling cascade and an attractive starting point to the development of potential new therapeutics targeting hypoxia signalling.
KW - Chemical tools
KW - Small molecules
KW - Target validaiton
U2 - 10.1038/ncomms13312
DO - 10.1038/ncomms13312
M3 - Journal article
C2 - 27811928
VL - 7
JO - Nature Communications
JF - Nature Communications
SN - 2041-1723
M1 - 13312
ER -